PTCT
PTC Therapeutics Inc
62.30$
-5.5%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 347.7% | 331.3% | 142.2% | 2.4% | 4.8% | 4.0% | 5.0% | 6.0% | 6.4% | 7.0% | 7.1% | 4.1% | |
| -247.7% | 100.0% | 100.0% | 97.6% | 95.2% | 96.0% | 95.0% | 94.0% | 93.6% | 93.0% | 92.9% | 95.9% | |
| 347.7% | 331.3% | 142.2% | 60.4% | 65.0% | 83.9% | 125.4% | 100.4% | 93.2% | 71.1% | 66.2% | 26.3% | |
| 195.2% | 223.2% | 117.4% | 62.4% | 58.0% | 66.0% | 64.4% | 53.0% | 42.9% | 37.2% | 37.3% | 20.1% | |
| 532.9% | 554.6% | 259.7% | 130.7% | 131.6% | 174.6% | 208.4% | 163.5% | 157.6% | 139.9% | 130.4% | 46.4% | |
| -432.9% | -454.6% | -159.7% | -33.1% | -43.7% | -78.6% | -113.4% | -69.5% | -64.0% | -46.9% | -37.5% | 49.5% | |
| 5.1% | 6.4% | 10.0% | 6.2% | 4.7% | 4.1% | 14.8% | 16.0% | 13.0% | 13.8% | 20.7% | 8.8% | |
| -428.7% | -462.3% | -171.1% | -40.0% | -48.4% | -78.2% | -105.8% | -96.2% | -84.1% | -74.2% | -45.0% | 40.3% | |
| -20.4% | 1.3% | 0.7% | 0.7% | 0.0% | 3.8% | 9.3% | 1.0% | -4.1% | -7.4% | 0.0% | 0.8% | |
| -408.3% | -463.6% | -171.8% | -40.6% | -48.4% | -82.0% | -115.1% | -97.3% | -80.0% | -66.8% | -45.0% | 39.4% | |
| -423.2% | -446.8% | -155.7% | -24.0% | -33.8% | -63.6% | -79.6% | -68.4% | -52.6% | -35.2% | -14.9% | 51.3% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.